12:00 AM
 | 
Oct 04, 1999
 |  BC Week In Review  |  Company News  |  Deals

Gene Logic, UCB Pharma Inc. deal

GLGC will apply its READS technology to develop a database of mast cell genes differentially expressed in asthma and...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >